{{Infobox|name         = Infobox/doc
|bodystyle    =
|above        = Giant-cell glioblastoma
|abovestyle   = background:lightgrey;
|image        = [[File:AFIP-00405562-GiantCellGlioblastoma-Gross.jpg|200px]]
|imagestyle   =
|caption      = Some glioblastomas, such as this giant-cell variant, are discrete firm masses which clinically and radiographically simulate metastatic carcinoma
|captionstyle =
|headerstyle  = background:lightgrey;
|labelstyle   =
|datastyle    =
|header1 = [[WHO classification of the tumors of the central nervous system|WHO Classification]]
|label2  = Standard name
|data2   = Giant-cell glioblastoma
|label3  = Structure
|data3   = '''''Neuroepithelial tumors'''''<br />└►'''Astrocytic tumors'''<br />└►''Glioblastoma''<br />└►Giant-cell glioblastoma
|header4 = [[International Classification of Diseases for Oncology|ICD-O Code]] & [[Grading of the tumors of the central nervous system|WHO Grade]]
|header5 =
|label5  = ICD-O Code
|data5   = 9441/3
|header6 =
|label6  = WHO Grade
|data6   = IV
|header7 = Synonyms & Acronyms
|header8 =
|label8  = Synonyms
|data8   = Monstrocellular sarcoma
|header9 = Epidemiology
|label10  = Incidence
|data10   = 0.15/100,000/y<br />new cases/population/year
|header11 =
|label11  = Age peak
|data11   = 42
|header12 =
|label12  = M/F ratio
|data12   = 1.6
|header13 = Prognosis
|header14 =
|label14  = Mean overall survival
|data14   = 12 months
|belowstyle = background:lightgrey;
|below = [[Wikipedia:WikiProject Medicine/Neurology task force|Medicine WikiProject/Neurology task force]]
}}

The '''giant-cell glioblastoma''' is a histological variant of [[glioblastoma]], presenting a prevalence of bizarre, multinucleated (more than 20 nuclei) giant (up to 400 μm diameter) cells.

It occasionally shows an abundant stromal reticulin network and presents a high frequency of ''TP53'' gene mutations.<ref name=Ohgaki_2000>{{Cite book|author=Ohgaki H, Peraud A, Nakazato Y, Watanabe K, von Deimling A |year=2000 |chapter=Giant cell glioblastoma |editor=Kleihues P and Cavenee WK |title=Pathology and Genetics of Tumours of the Nervous System |publisher=IARC |location=Lyon |isbn=92-832-2409-4}}{{Page needed|date=September 2010}}</ref><ref name=Macchi_2005>{{Cite book|author=Macchi G. |origyear=1981 |year=2005 |title=Malattie del sistema nervoso |publisher=PICCIN Editore |isbn=88-299-1739-7}}{{Page needed|date=September 2010}}</ref>

Symptoms and signs are similar to those of the ordinary glioblastoma. Methodology of diagnosis and treatment are the same.

Prognosis is similar to the ordinary glioblastoma (about 12 months).<ref name=DeAngelis_2007>{{Cite book|author=DeAngelis LM, Loeffler JS, Adam N. Mamelak AN |year=2007 |chapterurl=http://www.cancernetwork.com/cancer-management/chapter26/article/10165/1244368 |chapter=Primary and Metastatic Brain Tumors |editor=Pazdur R, Coia LR, Hoskins WJ, and Wagman LD |title=Cancer Management: A Multidisciplinary Approach |edition=10th |accessdate=4 August 2009 |format=subscription required}}{{Page needed|date=September 2010}}</ref> Some authors (see later) refer cases with a slightly better outcome.

==Historical annotation==
The giant-cell glioblastoma was originally termed "monstrocellular sarcoma", because of its stromal reticulin network,<ref>{{Cite book|author=Zulch KJ |year=1979 |title=Histological Typing of Tumours of the Central Nervous System |publisher=World Health Organization |location=Geneva |isbn=978-92-4-176021-8 |oclc=6845931}}{{Page needed|date=September 2010}}</ref><ref>{{Cite book|author=Zulch KJ |year=1986 |title=Brain Tumors: Their Biology and Pathology |edition=3rd |publisher=Springer Verlag |location=Berlin Heidelberg |isbn=978-0-387-10933-6}}{{Page needed|date=September 2010}}</ref> but the astrocytic nature of the tumor was firmly established through the consistent GFAP expression analysis.<ref>{{Cite journal|author=Jacque CM, Kujas M, Poreau A, ''et al.'' |title=GFA and S 100 protein levels as an index for malignancy in human gliomas and neurinomas |journal=Journal of the National Cancer Institute |volume=62 |issue=3 |pages=479–83 |year=1979 |month=March |pmid=216839 |issn=0027-8874}}</ref><ref>{{Cite book|author=Kleihues P, Burger PC, Scheithauer BW |year=1993 |title=Histological Typing of Tumours of the Central Nervous System |publisher=Springer Verlag |edition=2nd |location=Berlin Heidelberg |isbn=978-3-540-56971-8}}{{Page needed|date=September 2010}}</ref><ref>{{Cite book|author=Russell DS, Rubinstein LJ |year=1989 |title=Pathology of Tumors of the Nervous System |edition=5th |publisher=Edward Arnold |location=London}}{{Page needed|date=September 2010}}</ref>

==Epidemiology==
===Incidence===
The giant-cell glioblastoma is a rare neoplasia: its incidence is less than 1% of all brain tumors. It represents up to 5% of glioblastomas.<ref name=Palma1989>{{Cite journal|author=Palma L, Celli P, Maleci A, Di Lorenzo N, Cantore G |title=Malignant monstrocellular brain tumours. A study of 42 surgically treated cases |journal=Acta Neurochirurgica |volume=97 |issue=1–2 |pages=17–25 |year=1989 |pmid=2718792 |doi=10.1007/BF01577735 |issn=0001-6268}}</ref>

===Age and sex distribution===
The mean age at clinical presentation is 42. The age distribution includes children and has a wider range than other diffuse astrocytomas (diffuse WHO grade II astrocytoma, anaplastic astrocytoma, ordinary glioblastoma).<ref name=Palma1989/><ref>{{Cite journal|author=Meyer-Puttlitz B, Hayashi Y, Waha A, ''et al.'' |title=Molecular genetic analysis of giant-cell glioblastomas |journal=The American Journal of Pathology |volume=151 |issue=3 |pages=853–7 |year=1997 |month=September |pmid=9284834 |pmc=1857850 |issn=0002-9440}}</ref><ref>{{Cite journal|author=Peraud A, Watanabe K, Plate KH, Yonekawa Y, Kleihues P, Ohgaki H |title=p53 mutations versus EGF receptor expression in giant-cell glioblastomas |journal=Journal of Neuropathology and Experimental Neurology |volume=56 |issue=11 |pages=1236–41 |year=1997 |month=November |pmid=9370234 |doi=10.1097/00005072-199711000-00008 |issn=0022-3069}}</ref>

The giant-cell glioblastoma affects males more frequently. (The M/F ratio is 1.6.)<ref name=Ohgaki_2000/>

==Prognosis==
Most patients with giant-cell glioblastoma have unfavourable prognosis,<ref>{{Cite journal|author=Huang MC, Kubo O, Tajika Y, Takakura K |title=A clinico-immunohistochemical study of giant cell glioblastoma |journal=Nōshuyō Byōri |volume=13 |issue=1 |pages=11–6 |year=1996 |month=April |pmid=8916121 |issn=0914-8108 |url=http://www.nlm.nih.gov/medlineplus/braincancer.html |format=Free full text}}</ref> but some authors report clinical results slightly better than the ordinary glioblastoma,<ref>{{Cite journal|author=Margetts JC, Kalyan-Raman UP |title=Giant-celled glioblastoma of brain. A clinico-pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure) |journal=Cancer |volume=63 |issue=3 |pages=524–31 |year=1989 |month=February |pmid=2912529 |doi=10.1002/1097-0142(19890201)63:3<524::AID-CNCR2820630321>3.0.CO;2-D |issn=0008-543X |url=http://www.nlm.nih.gov/medlineplus/braincancer.html |format=Free full text}}</ref><ref>{{Cite journal|author=Shinojima N, Kochi M, Hamada J, ''et al.'' |title=The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme |journal=Journal of Neurosurgery |volume=101 |issue=2 |pages=219–26 |year=2004 |month=August |pmid=15309911 |doi=10.3171/jns.2004.101.2.0219 |issn=0022-3085}}</ref><ref>{{Cite journal|author=Becker DP, Benyo R, Roessmann U |title=Glial origin of monstrocellular tumor. Case report of prolonged survival |journal=Journal of Neurosurgery |volume=26 |issue=1 |pages=72–7 |year=1967 |month=January |pmid=6018784 |doi=10.3171/jns.1967.26.1part1.0072 |issn=0022-3085 |url=http://www.nlm.nih.gov/medlineplus/braincancer.html |format=Free full text}}</ref><ref>{{Cite journal|author=Burger PC, Vollmer RT |title=Histologic factors of prognostic significance in the glioblastoma multiforme |journal=Cancer |volume=46 |issue=5 |pages=1179–86 |year=1980 |month=September |pmid=6260329 |doi=10.1002/1097-0142(19800901)46:5<1179::AID-CNCR2820460517>3.0.CO;2-0 |issn=0008-543X |url=http://www.nlm.nih.gov/medlineplus/braincancer.html |format=Free full text}}</ref><ref>{{Cite journal|author=Klein R, Mölenkamp G, Sörensen N, Roggendorf W |title=Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period |journal=Child's Nervous System |volume=14 |issue=6 |pages=288–91 |year=1998 |month=June |pmid=9694343 |doi=10.1007/s003810050228 |issn=0256-7040}}</ref> in all probability because this variant seems less infiltrative, due to the nature of giant cells of this type.<ref name=Ohgaki_2000/>

==See also==
*[[Glioblastoma]]
*[[WHO classification of the tumors of the central nervous system]]
*[[Grading of the tumors of the central nervous system]]

==References==
{{Reflist|2}}

{{Central nervous system tumors}}

{{DEFAULTSORT:Giant-cell Glioblastoma}}
[[Category:Brain tumor]]